Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Sleep InertiaCaffeinePlacebo
Interventions
DIETARY_SUPPLEMENT

Caffeine

The 160 mg caffeine pulsatile-release formulation was manufactured using a drug layering process. Caffeine and the excipients are dispersed in the coating media and then sprayed onto inert microcrystalline cellulose spheres using a fluid bed through a Wurster tube with continuous inlet air that dries the liquid in the dispersion, to obtain various layers consisting of caffeine and release-controlling polymers. The applied release-controlling polymeric system is based on methacrylate copolymers, which control the release of caffeine in pH-dependent and pH-independent manner. The release mechanism of the polymeric system is mainly driven by the swellability and permeability of the copolymers. The final micropellets are then encapsulated into hydroxypropylmethylcellulose capsules.

OTHER

Placebo

Identical hydroxypropylmethylcellulose capsules without containing caffeine micropellets.

Trial Locations (1)

8057

University of Zurich, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Lokman Hekim University

OTHER_GOV

collaborator

Elixir Pharmaceuticals

INDUSTRY

lead

University of Zurich

OTHER